80 years of wind and rain, the inheritance and responsibility of "red medicine enterprises"



In 1943, in a few simple civilian houses, the predecessor of our Party and our army's first pharmaceutical factory was born. After that, the pharmaceutical factory with high hopes was named "Xinhua", which means "new China will replace old China".

Eighty years of changes, the new era of China has been proud of the world. 80 years of wind and rain, along the way, Xinhua Pharmaceutical has also created many first, shaped countless miracles, witness and promote the development of new China's pharmaceutical industry.

Whether it is a pharmaceutical team of 18 people at the beginning, or a modern pharmaceutical company with annual revenue of 7.5 billion yuan today; Whether in the period of the Anti-Japanese War, or in the face of the "5.12 earthquake" and the new coronavirus epidemic, Xinhua Pharmaceutical has always put the life and health of the people in the first place, and has practiced the responsibility and responsibility of a "red drug company".

01 Birth, and struggle for New China

At the beginning of its establishment, Xinhua Pharmaceutical was placed on high hopes.

1943 was the key period of the Anti-Japanese War, the Japanese invaders to the Eighth Route Army was completely blocked, the supply lines to the anti-Japanese base in Jiaodong were all cut off, military supplies and medical equipment shortage, the establishment of the Eighth Route Army's own medicine and medical equipment production organization is imminent.

In November of that year, 18 soldiers of the Eighth Route Army who had a certain medical knowledge base were ordered to form a pharmaceutical group in Muping County to develop and produce drugs. After that, the pharmaceutical team was relocated several times, the personnel continued to expand, the production scale also continued to expand, and gradually grew into Xinhua Pharmaceutical Factory, which made a non-negligible contribution to the victory of the Anti-Japanese War and the War of liberation.

In that difficult war period, Xinhua Pharmaceutical broke through many difficulties and firmly grew.

In 1945, tablets were produced by hand tablet press, and in 1946, injections began to be produced. Xinhua Pharmaceutical became the only pharmaceutical factory founded by our Party at that time that could produce preparations, meeting more than 60% of the military needs of the Jiaodong Military Region for drugs, medical equipment and health materials.

 Xinhua Pharmaceutical, whose production targets shifted from military to civilian, planted the seeds of the pharmaceutical industry in Shandong, only to have time for it to grow into a towering tree.

In the 1950s, the Central Ministry of Chemical Industry determined that Xinhua Pharmaceutical Factory to antipyretic and analgesic drugs as the development direction, Xinhua Pharmaceutical became the national antipyretic and analgesic drugs production base, which later became the world's important antipyretic and analgesic drugs production and export base.

In 1950, Xinhua Pharmaceutical successfully developed antimony sodium gluconate and put out kala-azar in one fell fell. In 1953, the first glass-lined reaction tank in New China was developed. In 1955, the first large-scale chemical synthetic raw material workshop in China was built, with an annual output of 100 tons of finaxetine workshop. In 1963, the annual production capacity of 100 tons of Anaijin workshop was completed and put into operation; In 1985, "Xinhua" brand piperidol tablets, as a new chemical synthetic antibiotic of chloranone exclusively produced in China, filled the gap in domestic medicine...... Numerous firsts have witnessed the growth of Xinhua Pharmaceutical.

Xinhua Pharmaceutical has also sent a large number of cadres and technical personnel to help build large national backbone pharmaceutical enterprises such as North China Pharmaceutical and Northwest Second Synthetic Pharmaceutical, laying the foundation for the development of China's chemical and pharmaceutical industry and creating a new era of China's chemical and pharmaceutical industrialization.

Today, Xinhua Pharmaceutical has a number of product lines such as pharmaceutical intermediates, high-quality apis, high-end preparations to commercial sectors, with a number of domestic exclusive varieties, a number of leading varieties in the world's forefront, of which the annual production capacity of apis has reached 50,000 tons, supporting intermediates capacity of 500,000 tons, annual revenue of more than 7.5 billion yuan.

02 Inheritance, all for the people

From its establishment to development, Xinhua Pharmaceutical, which inherits the red gene, has always adhered to a belief - "Everything is for the people". In order to achieve this goal and practice the mission of "protecting health and benefiting society", Xinhua Pharmaceutical is even willing to go against the profit "instinct" of enterprise development and sacrifice vital interests.

In New China Pharmaceutical, there is not only no profit from sales, but even to take money in the drug, this is the exclusive product of New China Pharmaceutical acetamide injection. Acetamide injection is a special antidote for poisoning such as organic fluorine insecticide and rodenticide fluoroacetamide. Because of its short shelf life and few uses, this drug not only has no sales profit, but even loses money.

However, for patients who are unlucky enough to be poisoned, it is a life-saving drug.

In the past few years, news of Xinhua Pharmaceutical sending medicine thousands of miles occurred frequently. In 1995, Xinhua Pharmaceutical sent medicine thousands of miles to save nearly 300 poisoning patients in Pingchuan District, Baiyin City, Gansu Province; In 2007, 203 patients at the Heilongjiang Academy of Traditional Chinese Medicine were rescued. In 2011, emergency medicine delivery for victims of a vicious poisoning incident in Tangshan, Hebei Province; In 2019, Baili urgently sent life-saving medicine to rescue 19-month baby girl Muqi; In 2021, Xinhua Pharmaceutical staff traveled 300 kilometers to Huaian to deliver drugs to patients.......

 In March this year, Xinhua Pharmaceutical acetamide chemical raw materials have also been approved for listing.

A drug that "does not make money" can save precious lives, for the "red drug enterprise" of Xinhua Pharmaceutical, the "great justice" of benefiting society is higher than the "small profit" of the enterprise itself.

In 2008, the "5.12" Wenchuan earthquake drew the hearts of the people of the whole country. Ten hours after the earthquake, the first batch of 600,000 yuan of emergency medicine donated by Xinhua Pharmaceutical was airdropped to the Wenchuan disaster area at the first time, and then donated more than 3.2 million yuan of medicine and money for the disaster area. In 2008 "April 28" Jiaoji railway accident, 2010 "April 14" Yushu earthquake and other major events, Xinhua Pharmaceutical also actively donated love drugs, demonstrating the moral responsibility and social responsibility of the enterprise.

Xinhua Pharmaceutical won the "China Pharmaceutical Enterprise Social Responsibility Contribution Award", is the "National support for public welfare, caring for people's health enterprise", Shandong Province unpaid blood donation advanced collective, Zibo Charity Award the most caring enterprise.

03 Bear, go all out to ensure supply

Within a week, the daily production capacity of ibuprofen was expanded by 17 times, which is another miracle shaped by Xinhua Pharmaceutical.

Last winter, there was a shortage of antipyretic and analgesic drugs in many places in the country, and ibuprofen was difficult to find. Ibuprofen, acetaminophen, aspirin, loratadine, cetirizine and other drugs produced by Xinhua Pharmaceutical are listed in the Reference list of common drugs used in the home treatment of COVID-19 patients.

As the world's largest ibuprofen API production base and an old state-owned enterprise, Xinhua Pharmaceutical took urgent action.

Including the research staff of the Research Institute, more than 1,000 employees of Xinhua Pharmaceutical rushed to the production line, ate and lived in the factory, and a number of intelligent production lines produced at full capacity 24 hours, with a cumulative supply of more than 1,000 tons of ibuprofen apis. At the same time, ibuprofen tablets, vitamin C tablets and other urgently needed drugs have also increased production and expanded production, stepping up supply to the market and stabilizing social demand.

This drug defense war also closely linked enterprises, regulatory departments and the people.

Previously, the main packaging specification of ibuprofen produced by Xinhua Pharmaceutical was 100 tablets/bottle. In order to allow more people to use urgently needed drugs as soon as possible, Xinhua Pharmaceutical urgently submitted 12 pieces/box of small specifications aluminum-plastic packaging for record. Many departments of the Shandong Food and Drug Administration stepped up coordination, intervened in advance from data declaration to process inspection, stability inspection and other links, accelerated the promotion, and finally completed the approval process of the new packaging specifications in only 4 hours, allowing more people to use assured drugs.

From scratch to excellent, Xinhua Pharmaceutical has led the development of China's chemical and pharmaceutical industry; Give up small profits, bear the great justice, Xinhua Pharmaceutical continues to benefit the people; With positive response and commitment, Xinhua Pharmaceutical goes all out to ensure people's livelihood and supply......

The red spirit has penetrated into the blood of Xinhua Pharmaceutical. Whenever the country and the people need, Xinhua Pharmaceutical will stand up to the difficulties, shoulder the responsibility of state-owned enterprises, and practice the mission of "protecting health and benefiting society".